Viracta Therapeutics Inc (NASDAQ:VIRX)
| 6.08 Delayed Data As of Oct 21 |  -0.12 / -1.94%Today’s Change | 3.92 Today|||52-Week Range 24.80 | -12.71% Year-to-Date |
Latest VIRX News | Press Releases
No recent news for Viracta Therapeutics Inc.
Today’s Trading
| Previous close | 6.20 |
| Today’s open | 6.31 |
| Day’s range | 6.05 - 6.35 |
| Volume | 4,595 |
| Average volume (3 months) | 229,898 |
| Market cap | $237.4M |
Data as of 3:59pm ET, 10/21/2021
Growth & Valuation
| Earnings growth (last year) | +42.73% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -94.21% |
| P/E ratio | -- |
| Price/Sales | 233.71 |
| Price/Book | 2.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVEOAveo Pharmaceuticals... | -0.04 | -0.60% |
| FENCFennec Pharmaceutica... | -0.26 | -2.87% |
| TCDATricida Inc | +0.02 | +0.45% |
| INFIInfinity Pharmaceuti... | -0.01 | -0.19% |
Data as of 3:59pm ET, 10/21/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $120.0K |
| Annual profit (last year) | -$21.6M |
| Net profit margin | -18,008.33% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cardiff, California |
Forecasts
